• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs、lncRNAs 和环状 RNAs 作为高血压相关血管平滑肌细胞功能障碍的介质。

MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

机构信息

Department of Anesthesiology, Affiliated Hospital of Jiangnan University, 214062, Wuxi, PR China.

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, Jiangsu, PR China.

出版信息

Hypertens Res. 2021 Feb;44(2):129-146. doi: 10.1038/s41440-020-00553-6. Epub 2020 Sep 23.

DOI:10.1038/s41440-020-00553-6
PMID:32985618
Abstract

Hypertension is a multifactorial disorder that involves complex genetic and environmental factors. Vascular smooth muscle cells (VSMCs) are important components of blood vessels, and their dysregulation has been shown to be involved in vascular remodeling during the development of systemic hypertension and pulmonary arterial hypertension (PAH) via multiple mechanisms, such as aberrant apoptosis, phenotype conversion, proliferation, and migration of VSMCs. With increasing advances in microarrays and next-generation sequencing, nonprotein-coding RNAs (ncRNAs) have attracted much attention due to their numerous functions in health and diseases. Among ncRNAs, microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs are emerging as novel modulators in the biological behaviors of VSMCs, especially in systemic hypertension and PAH. Studies have recommended miRNAs, lncRNAs, and circular RNAs as predictive biomarkers and therapeutic targets for systemic hypertension and PAH. In this review, we summarize the current studies focusing on the roles of VSMC-derived miRNAs, lncRNAs and circular RNAs in the pathologies of systemic hypertension and PAH. MiRNAs, lncRNAs, and circular RNAs might serve as attractive targets for the prevention and treatment of VSMC dysfunction-linked systemic hypertension and PAH.

摘要

高血压是一种涉及复杂遗传和环境因素的多因素疾病。血管平滑肌细胞(VSMCs)是血管的重要组成部分,其功能失调已被证明通过多种机制参与系统性高血压和肺动脉高压(PAH)的血管重塑,例如 VSMCs 的异常凋亡、表型转换、增殖和迁移。随着微阵列和下一代测序技术的不断进步,由于非编码 RNA(ncRNA)在健康和疾病中的多种功能,它们引起了广泛关注。在 ncRNA 中,微小 RNA(miRNA)、长非编码 RNA(lncRNA)和环状 RNA 作为 VSMCs 生物学行为的新型调节剂而崭露头角,特别是在系统性高血压和 PAH 中。研究表明,miRNA、lncRNA 和环状 RNA 可作为系统性高血压和 PAH 的预测生物标志物和治疗靶点。在这篇综述中,我们总结了目前关于 VSMC 来源的 miRNA、lncRNA 和环状 RNA 在系统性高血压和 PAH 病理中的作用的研究。miRNA、lncRNA 和环状 RNA 可能成为预防和治疗与 VSMC 功能障碍相关的系统性高血压和 PAH 的有吸引力的靶点。

相似文献

1
MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.miRNAs、lncRNAs 和环状 RNAs 作为高血压相关血管平滑肌细胞功能障碍的介质。
Hypertens Res. 2021 Feb;44(2):129-146. doi: 10.1038/s41440-020-00553-6. Epub 2020 Sep 23.
2
LncRNAs and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential.长链非编码 RNA 和环状 RNA 作为高血压中内皮细胞的信使:机制见解和治疗潜力。
Mol Biol Rep. 2020 Jul;47(7):5535-5547. doi: 10.1007/s11033-020-05601-5. Epub 2020 Jun 21.
3
Long noncoding RNAs as novel players in the pathogenesis of hypertension.长非编码 RNA 作为高血压发病机制中的新角色。
Hypertens Res. 2020 Jul;43(7):597-608. doi: 10.1038/s41440-020-0408-2. Epub 2020 Feb 5.
4
ncRNAs and polyphenols: new therapeutic strategies for hypertension.ncRNAs 和多酚:高血压的新治疗策略。
RNA Biol. 2022;19(1):575-587. doi: 10.1080/15476286.2022.2066335. Epub 2021 Dec 31.
5
Noncoding RNAs in vascular smooth muscle cell function and neointimal hyperplasia.非编码 RNA 在血管平滑肌细胞功能和新生内膜增生中的作用。
FEBS J. 2020 Dec;287(24):5260-5283. doi: 10.1111/febs.15357. Epub 2020 May 22.
6
Circular RNAs: regulators of vascular smooth muscle cells in cardiovascular diseases.环状 RNA:心血管疾病中血管平滑肌细胞的调控因子。
J Mol Med (Berl). 2022 Apr;100(4):519-535. doi: 10.1007/s00109-022-02186-3. Epub 2022 Mar 7.
7
Functional Long Non-coding RNAs in Vascular Smooth Muscle Cells.血管平滑肌细胞中的功能性长链非编码RNA
Curr Top Microbiol Immunol. 2016;394:127-41. doi: 10.1007/82_2015_441.
8
LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.长链非编码 RNA-TCONS_00034812 对肺动脉平滑肌细胞增殖和凋亡的影响及其机制。
J Cell Physiol. 2018 Jun;233(6):4801-4814. doi: 10.1002/jcp.26279. Epub 2018 Jan 15.
9
The Landscape of Noncoding RNA in Pulmonary Hypertension.非编码 RNA 在肺动脉高压中的全景。
Biomolecules. 2022 Jun 7;12(6):796. doi: 10.3390/biom12060796.
10
Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells.新型长非编码 RNA 受血管平滑肌细胞中血管紧张素 II 的调控。
Circ Res. 2013 Jul 19;113(3):266-78. doi: 10.1161/CIRCRESAHA.112.300849. Epub 2013 May 22.

引用本文的文献

1
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.硫化氢作为肺动脉高压的新治疗靶点:免疫调节最新进展综述
Front Pharmacol. 2025 May 12;16:1510275. doi: 10.3389/fphar.2025.1510275. eCollection 2025.
2
Impact of Sorbs2 dysfunction on cardiovascular diseases.Sorbs2功能障碍对心血管疾病的影响。
Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167813. doi: 10.1016/j.bbadis.2025.167813. Epub 2025 Mar 24.
3
Comparative Analysis of Circular RNAs Expression and Function between Aortic and Intracranial Aneurysms.

本文引用的文献

1
Interaction between N-methyladenosine (mA) modification and noncoding RNAs in cancer.N6-甲基腺苷(m6A)修饰与癌症中非编码 RNA 的相互作用。
Mol Cancer. 2020 May 22;19(1):94. doi: 10.1186/s12943-020-01207-4.
2
Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.血管紧张素转换酶抑制剂对动脉僵硬度的影响:随机对照试验的系统评价和荟萃分析。
Cardiovasc Ther. 2020 Feb 25;2020:7056184. doi: 10.1155/2020/7056184. eCollection 2020.
3
Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products.
主动脉瘤与颅内动脉瘤中环状 RNA 的表达与功能比较分析。
Curr Drug Targets. 2024;25(13):866-884. doi: 10.2174/0113894501319306240819052840.
4
MiR-196a-5p hinders vascular smooth muscle cell proliferation and vascular remodeling via repressing BACH1 expression.miR-196a-5p 通过抑制 BACH1 表达抑制血管平滑肌细胞增殖和血管重构。
Sci Rep. 2024 Jul 23;14(1):16904. doi: 10.1038/s41598-024-68122-2.
5
Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension.低氧诱导肺动脉高压中程序性细胞死亡的表观遗传调控。
Front Immunol. 2023 Sep 11;14:1206452. doi: 10.3389/fimmu.2023.1206452. eCollection 2023.
6
MiR-155-5p Attenuates Vascular Smooth Muscle Cell Oxidative Stress and Migration via Inhibiting BACH1 Expression.微小RNA-155-5p通过抑制BACH1表达减轻血管平滑肌细胞氧化应激和迁移。
Biomedicines. 2023 Jun 9;11(6):1679. doi: 10.3390/biomedicines11061679.
7
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.血管功能和高血压中的信号通路:分子机制和治疗干预。
Signal Transduct Target Ther. 2023 Apr 20;8(1):168. doi: 10.1038/s41392-023-01430-7.
8
β‑aminoisobutyric acid ameliorates hypertensive vascular remodeling via activating the AMPK/SIRT1 pathway in VSMCs.β-氨基异丁酸通过激活血管平滑肌细胞中的 AMPK/SIRT1 通路改善高血压血管重塑。
Bioengineered. 2022 Jun;13(6):14382-14401. doi: 10.1080/21655979.2022.2085583.
9
Epigenetic Mechanisms Involved in Inflammaging-Associated Hypertension.炎症相关高血压的表观遗传机制。
Curr Hypertens Rep. 2022 Nov;24(11):547-562. doi: 10.1007/s11906-022-01214-4. Epub 2022 Jul 7.
10
Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.小儿先天性心脏病相关性肺动脉高压中失调环状RNA的生物信息学分析
Transl Pediatr. 2022 May;11(5):715-727. doi: 10.21037/tp-22-117.
心血管药物与植物产品的药代动力学相互作用。
Cardiovasc Ther. 2019 Sep 2;2019:9402781. doi: 10.1155/2019/9402781. eCollection 2019.
4
miR-96-5p Regulates Proliferation, Migration, and Apoptosis of Vascular Smooth Muscle Cell Induced by Angiotensin II via Targeting NFAT5.微小RNA-96-5p通过靶向核因子活化T细胞5调控血管紧张素II诱导的血管平滑肌细胞增殖、迁移和凋亡。
J Vasc Res. 2020;57(2):86-96. doi: 10.1159/000505457. Epub 2020 Feb 11.
5
Circ- Serves as an Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation.环状 RNA 作为海绵体调节肌球蛋白 10 并促进肺动脉平滑肌增殖。
Hypertension. 2020 Mar;75(3):668-679. doi: 10.1161/HYPERTENSIONAHA.119.13715. Epub 2020 Feb 3.
6
Downregulation of long non‑coding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells.长链非编码 RNA ANRIL 的下调促进低氧人肺动脉平滑肌细胞的增殖和迁移。
Mol Med Rep. 2020 Feb;21(2):589-596. doi: 10.3892/mmr.2019.10887. Epub 2019 Dec 17.
7
MiR155-5p in adventitial fibroblasts-derived extracellular vesicles inhibits vascular smooth muscle cell proliferation via suppressing angiotensin-converting enzyme expression.外膜成纤维细胞衍生的细胞外囊泡中的MiR155 - 5p通过抑制血管紧张素转换酶表达来抑制血管平滑肌细胞增殖。
J Extracell Vesicles. 2019 Dec 2;9(1):1698795. doi: 10.1080/20013078.2019.1698795. eCollection 2020.
8
Suppression of circDcbld1 Alleviates Intimal Hyperplasia in Rat Carotid Artery by Targeting miR-145-3p/Neuropilin-1.靶向miR-145-3p/神经纤毛蛋白-1抑制circDcbld1可减轻大鼠颈动脉内膜增生
Mol Ther Nucleic Acids. 2019 Dec 6;18:999-1008. doi: 10.1016/j.omtn.2019.10.023. Epub 2019 Oct 28.
9
Hsa_circ_0046159 is involved in the development of chronic thromboembolic pulmonary hypertension.Hsa_circ_0046159 参与慢性血栓栓塞性肺动脉高压的发生发展。
J Thromb Thrombolysis. 2020 Apr;49(3):386-394. doi: 10.1007/s11239-019-01998-4.
10
Long noncoding RNA-dependent regulation of vascular smooth muscle cell proliferation and migration in hypertension.长非编码 RNA 依赖性调控高血压血管平滑肌细胞增殖和迁移。
Int J Biochem Cell Biol. 2020 Jan;118:105653. doi: 10.1016/j.biocel.2019.105653. Epub 2019 Nov 16.